globenewswire

NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public.

NEWARK, Del., July 01, 2025 (GLOBE NEWSWIRE) -- Artesian Resources Corporation (Nasdaq: ARTNA), a leading provider of water and wastewater services in the Delmarva region, which includes operations in Delaware, Maryland and Pennsylvania, is pleased to announce the appointment of Salvatore J. “Chip” Rossi to its Board of Directors. Mr. Rossi is an experienced financial expert with extensive knowledge in risk management.

NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of DoubleVerify Holdings, Inc. (NYSE: DV) between November 10, 2023 and February 27, 2025, both dates inclusive (the “Class Period”), of the important July 21, 2025 lead plaintiff deadline.

New York City, NY, July 01, 2025 (GLOBE NEWSWIRE) --

BTCMiner is an intelligent cloud mining platform that helps global users easily enter the field of digital currency mining through simple operations and flexible investment methods. With its stable returns, zero-risk guarantee and innovative mining mechanism,

WeSalute offers unique airfare discounts for U.S. military and veterans planning trips and family vacations during the peak summer travel season

ST. LOUIS, July 01, 2025 (GLOBE NEWSWIRE) --

Today’s pet parents want real, whole-food nutrition that they can recognize and trust. That’s exactly what NEW Instinct® FreshRaw™ Meals deliver. This first-of-its-kind offering combines real, fresh ingredients you can see with the superior nutrition of raw. 

Press release – Paris, July 1^st, 2025, at 7:00 P.M. CEST

Communiqué de presse – Paris, le 1er juillet 2025, à 19h00

WINSTON-SALEM, N.C., July 01, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced the completion of the domestication process to change the jurisdiction of incorporation of the Company from the Cayman Islands to Delaware. The domestication was approved by shareholders of the Company at its Annual General Meeting held on May 29, 2025. Effective as of July 1, 2025, each (i) Class A ordinary share automatically converted into one share of Class A common stock of ProKidney Corp., a Delaware corporation and (ii) each Class B ordinary share automatically converted into one share of Class B common stock of ProKidney. ProKidney common stock will begin trading on July 2, 2025, and the Company's trading symbol on the Nasdaq Stock Market will remain unchanged as "PROK." The Company’s CUSIP number relating to its Class A common stock changed to 74291D 104. The Company does not anticipate any impact to day-to-day business operations as a result of the domestication.